Sectors
DMII
Drugs Made In America Acquisition II Corp.
10.14
1 x 10.11
2 x 10.09
bid
ask
+
0.00
0.00%
02:05 PM
timesize
| Ytd | 2.42% | |
| 1y | 2.63% |
10.13
day range
10.14
9.86
52 week range
10.21
| Open | 10.13 | Prev Close | 10.14 | Low | 10.13 | High | 10.14 | Mkt Cap | 645.92M |
| Vol | 62.08K | Avg Vol | 69.47K | EPS | 0.29 | P/E | 34.97 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 10.10 | 200-d Avg | 10.01 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | -112.23K | ||
| Selling, General and Administrative Expense | -112.23K | ||
| Operating Income | 112.23K | ||
| Net Income | 4.40M | ||
| Net Income Common Stock | 4.40M | ||
| Net Income Common Stock (USD) | 4.40M | ||
| Consolidated Income | 4.40M | ||
| Earnings per Basic Share | 0.07 | ||
| Earnings per Basic Share (USD) | 0.07 | ||
| Earnings per Diluted Share | 0.07 | ||
| Earning Before Interest & Taxes (EBIT) | 4.40M | ||
| Earning Before Interest & Taxes (USD) | 4.40M | ||
| Weighted Average Shares | 63.70M | ||
| Weighted Average Shares Diluted | 63.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 174.97K | ||
| Cash and Equivalents (USD) | 174.97K | ||
| Investments | 513.88M | ||
| Investments Non-Current | 513.88M | ||
| Current Assets | 217.82K | ||
| Total Assets | 514.10M | ||
| Debt Current | 450.00K | ||
| Total Debt | 450.00K | ||
| Current Liabilities | 644.57K | ||
| Total Liabilities | 18.14M | ||
| Accumulated Retained Earnings (Deficit) | -17.93M | ||
| Shareholders Equity | -17.93M | ||
| Shareholders Equity (USD) | -17.93M | ||
| Assets Non-Current | 513.88M | ||
| Total Debt (USD) | 450.00K | ||
| Liabilities Non-Current | 17.50M | ||
| Trade and Non-Trade Payables | 12.25K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -172.75K | ||
| Net Cash Flow from Operations | -172.75K | ||